Naturhouse HealthXMAD:NTH -1.94%77 PE Ratio (TTM) is 14.88 as of Jul. 02, 2026, which is 42% above its 10-year median of 10.47. GuruFocus rates XMAD:NTH with a GF Score™ of 77/100 and a GF Value™ of €1.62 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 1,426 Consumer Packaged Goods companies, Naturhouse Health ranks better than 52.31% on this metric.
The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2026-07-02), Naturhouse Health's share price is
€2.53.
Naturhouse Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €0.17. Therefore, Naturhouse Health's PE Ratio (TTM) for today is 14.88.
Warning Sign:
Naturhouse Health SA stock PE Ratio (=15.24) is close to 10-year high of 15.53.
The historical rank and industry rank for Naturhouse Health's PE Ratio (TTM) or its related term are showing as below:
XMAD:NTH'
s PE Ratio (TTM) Range Over the Past 10 Years
Min: 4.91 Med: 10.47 Max: 15.53
Current: 14.89
During the past 13 years, the highest PE Ratio (TTM) of Naturhouse Health was 15.53. The lowest was 4.91. And the median was 10.47.
XMAD:NTH's PE Ratio (TTM) is ranked better than 52.31% of 1426
companies
in the Consumer Packaged Goods industry
Industry Median: 15.74
vs XMAD:NTH: 14.89
During the past 12 months, Naturhouse Health's average EPS without NRIGrowth Rate was 1.80% per year.
During the past 3 years, the average EPS without NRIGrowth Rate was 1.60% per year.
During the past 5 years, the average EPS without NRIGrowth Rate was -2.50% per year.
During the past 10 years, the average EPS without NRIGrowth Rate was -8.70% per year.
During the past 13 years, Naturhouse Health's highest 3-Year average EPS without NRI Growth Rate was 39.20% per year. The lowest was -19.30% per year. And the median was -7.05% per year.
Naturhouse Health's EPS (Basic) for the
six
months ended in Dec. 2025 was €0.07.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 was €0.17.
Naturhouse Health (XMAD:NTH) PE Ratio (TTM) Explanation
The PE Ratio (TTM) can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio (TTM) is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.
In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio (TTM) is positive. Also for stocks with the same PE Ratio (TTM), the one with faster growth business is more attractive.
If a company loses money, the PE Ratio (TTM) becomes meaningless.
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio (TTM) divided by the growth ratio. He thinks a company with a PE Ratio (TTM) equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio (TTM) of 20, instead of a company growing 10% a year with a PE Ratio (TTM) of 10.
Because the PE Ratio (TTM) measures how long it takes to earn back the price you pay, the PE Ratio (TTM) can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.
Investors need to be aware that the PE Ratio (TTM) can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio (TTM)s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio (TTM) is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio .
PE Ratio (TTM) can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio (TTM).
Naturhouse Health PE Ratio (TTM) Related Terms
Naturhouse Health PE Ratio (TTM) Historical Data
* Premium members only.
The historical data trend for Naturhouse Health's PE Ratio (TTM) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XMAD:NTH vs KHC, GIS, HRL: PE Ratio (TTM) Comparison
For the Packaged Foods subindustry, Naturhouse Health's PE Ratio (TTM), along with its competitors' market caps and PE Ratio (TTM) data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Naturhouse Health PE Ratio (TTM) vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Naturhouse Health's PE Ratio (TTM) distribution charts can be found below:
* The bar in red indicates where Naturhouse Health's PE Ratio (TTM) falls into.
The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.
Naturhouse Health's Share Price of today is €2.53.
For company reported semi-annually, Naturhouse Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.17.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
There are at least three kinds of PE Ratio (TTM)s used by different investors. They are Trailing Twelve Month PE Ratio (TTM) or PE Ratio (TTM) (TTM), Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio (TTM) based on inflation-adjusted normalized PE Ratio (TTM) is called Shiller PE Ratio, after Yale professor Robert Shiller.
In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.
For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.
Naturhouse Health (XMAD:NTH) has a PE Ratio (TTM) of 14.88 as of Jul. 02, 2026. Trailing 12-month P/E ratio is the ratio of share price to a company's trailing 12-month earnings per share. View historical data on Naturhouse Health and its competitors. This is 42% above median its historical median of 10.47. Over the past decade, Naturhouse Health's PE Ratio (TTM) has ranged from 4.91 to 15.53. According to the industry distribution chart, Naturhouse Health ranks #680 out of 1426 companies in the Consumer Packaged Goods industry, placing it in the top 47.7%.
Is Naturhouse Health's PE Ratio (TTM) too high?
Naturhouse Health's current PE Ratio (TTM) of 14.88 is 42% above median its 10-year median of 10.47. Over the past 10 years, this metric has ranged from a low of 4.91 to a high of 15.53. The Consumer Packaged Goods industry median PE Ratio (TTM) is 15.74. Naturhouse Health's value of 14.88 is 5.5% below this industry median. Based on the distribution chart, Naturhouse Health ranks #680 out of 1426 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, Naturhouse Health has a GF Score™ of 77/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Naturhouse Health's PE Ratio (TTM) compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Naturhouse Health ranks #680 out of 1426 companies for PE Ratio (TTM). This puts Naturhouse Health in the upper half of its industry. The industry median PE Ratio (TTM) is 15.74. Naturhouse Health's value of 14.88 is 5.5% below this benchmark. Historically, Naturhouse Health's own PE Ratio (TTM) has ranged from 4.91 to 15.53 over the past decade. While the company's 10-year median is 10.47 vs. the industry median of 15.74, Naturhouse Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio (TTM) for a Consumer Packaged Goods company?
The median PE Ratio (TTM) among Consumer Packaged Goods companies is 15.74, based on 1,426 companies in the industry. Companies in the top quartile (top 25%) have a PE Ratio (TTM) significantly above this median, while those in the bottom quartile fall well below. However, PE Ratio (TTM) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Naturhouse Health's current PE Ratio (TTM) of 14.88 is 5.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio (TTM) mean?
A high PE Ratio (TTM) can signal that a stock is expensive relative to its fundamentals. Trailing 12-month P/E ratio is the ratio of share price to a company's trailing 12-month earnings per share. View historical data on Naturhouse Health and its competitors. For the Consumer Packaged Goods industry, the median PE Ratio (TTM) is 15.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Naturhouse Health's current PE Ratio (TTM) is 14.88, which is 42% above median its own 10-year median of 10.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Naturhouse Health stock overvalued right now?
Based on GuruFocus' analysis, Naturhouse Health (XMAD:NTH) is currently considered Significantly Overvalued. The stock's GF Value™ is €1.62, compared to a current price of €2.53 — trading 56.2% above its estimated fair value. The current PE Ratio (TTM) is 14.88, which is 42% above median its 10-year median of 10.47 and 5.5% below the Consumer Packaged Goods industry median of 15.74. Naturhouse Health's overall GF Score™ is 77/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio (TTM) calculated?
PE Ratio (TTM) is calculated from a company's financial statements. For Naturhouse Health (XMAD:NTH), the current PE Ratio (TTM) is 14.88 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Naturhouse Health (XMAD:NTH) Overvalued in 2026?
Based on GuruFocus' analysis, Naturhouse Health stock appears to be overvalued.
The current stock price of €2.53 is trading 56.2% above its estimated GF Value™ of €1.62.
GuruFocus considers Naturhouse Health to be Significantly Overvalued.
Key valuation signals for XMAD:NTH:
PE Ratio (TTM): 14.88 (42% above median its 10-year median of 10.47)
GF Value™: €1.62 vs. price of €2.53 (56.2% above fair value)
Industry Position: 5.5% below the Consumer Packaged Goods median (#680 of 1426)
No single metric tells the full story. See the XMAD:NTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Naturhouse Health SA provides nutrition & weight management products. The activity of the company is the export, wholesale, and retail sales of all kinds of products related to dietetics, herbal remedies, and natural cosmetics, as well as the preparation, promotion, creation, edition, dissemination, sale, and distribution of all kinds of magazines, books, and brochures and the marketing of dietary products, herbal remedies, and natural cosmetics. This activity is mainly carried out through franchisees and its stores. The geographical segments of the company are Spain, France, Italy, Poland, and Other countries.
77GF Score
Get the complete analysis for XMAD:NTH
PE Ratio (TTM) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XMAD:NTH has been successfully added to your 
